These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8726130)

  • 1. Positron emission tomography and plasma biochemistry findings in schizophrenic patients before and after electroconvulsive therapy.
    Uesugi H; Toyoda J; Iio M
    Psychiatry Clin Neurosci; 1995 May; 49(2):131-5. PubMed ID: 8726130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and subacute effects of ECT on plasma HVA, MHPG, and prolactin.
    Devanand DP; Bowers MB; Hoffman FJ; Sackeim HA
    Biol Psychiatry; 1989 Aug; 26(4):408-12. PubMed ID: 2765601
    [No Abstract]   [Full Text] [Related]  

  • 3. Time course of cerebral blood flow changes following electroconvulsive therapy in depressive patients--measured at 3 time points using single photon emission computed tomography.
    Takano H; Kato M; Inagaki A; Watanabe K; Kashima H
    Keio J Med; 2006 Dec; 55(4):153-60. PubMed ID: 17191070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma 3-methoxy-4-hydroxyphenylglycol changes associated with clinical state and schizophrenic subtype.
    Ko GN; Jimerson DC; Wyatt RJ; Bigelow LB
    Arch Gen Psychiatry; 1988 Sep; 45(9):842-6. PubMed ID: 3415425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in regional cerebral blood flow abnormalities in late-life depression following response to electroconvulsive therapy.
    Awata S; Konno M; Kawashima R; Suzuki K; Sato T; Matsuoka H; Fukuda H; Sato M
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):31-40. PubMed ID: 11929569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of delusional disorder, somatic type with remarkable improvement of clinical symptoms and single photon emission computed tomograpy findings following modified electroconvulsive therapy.
    Ota M; Mizukami K; Katano T; Sato S; Takeda T; Asada T
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):881-4. PubMed ID: 12921924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of electroconvulsive therapy on peripheral adrenoceptors, plasma, noradrenaline, MHPG and cortisol in depressed patients.
    Werstiuk ES; Coote M; Griffith L; Shannon H; Steiner M
    Br J Psychiatry; 1996 Dec; 169(6):758-65. PubMed ID: 8968635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The case of a depressed man who exhibited hyperprolactinemia and galactopoiesis after electroconvulsive therapy.
    Tokutsu Y; Umene-Nakano W; Yoshimura R; Katsuki A; Atake K; Nakamura J
    J ECT; 2012 Mar; 28(1):56. PubMed ID: 21778911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in regional cerebral blood flow during acute electroconvulsive therapy in patients with depression: positron emission tomographic study.
    Takano H; Motohashi N; Uema T; Ogawa K; Ohnishi T; Nishikawa M; Kashima H; Matsuda H
    Br J Psychiatry; 2007 Jan; 190():63-8. PubMed ID: 17197658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of cerebral glucose hypometabolism on positron emission tomography with electroconvulsive therapy in an elderly patient with a psychotic episode.
    Hassamal S; Jolles P; Pandurangi A
    Psychogeriatrics; 2016 Nov; 16(6):376-381. PubMed ID: 26756319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET in Cotard syndrome before and after treatment: can functional brain imaging support a two-factor hypothesis of nihilistic delusions?
    Restrepo-Martínez M; Espinola-Nadurille M; Bayliss L; Díaz-Meneses I; Kerik NE; Mendez MF; Ramírez-Bermúdez J
    Cogn Neuropsychiatry; 2019 Nov; 24(6):470-480. PubMed ID: 31597522
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the prolactin response induced by electroconvulsive therapy in schizophrenics.
    Arató M; Erdós A; Kurcz M; Vermes I; Fekete M
    Acta Psychiatr Scand; 1980 Mar; 61(3):239-44. PubMed ID: 7376927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electroconvulsive Therapy (ECT) of a 15-year-old female patient suffering from a severe delusional depression: a case report].
    Reinhardt M; Wunsch K; Weirich S; Häßler F; Buchmann J
    Z Kinder Jugendpsychiatr Psychother; 2018 Nov; 46(6):536-541. PubMed ID: 30084713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clonazepam treatment on antipsychotic drug-induced Meige syndrome and changes in plasma levels of GABA, HVA, and MHPG during treatment.
    Yoshimura R; Kakihara S; Soya A; Ueda N; Shinkai K; Nakamura J
    Psychiatry Clin Neurosci; 2001 Oct; 55(5):543-6. PubMed ID: 11555353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electroconvulsive therapy in treatment of resistant schizophrenia: biological markers of efficacy and safety].
    Ivanov MV; Zubov DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(3):92-97. PubMed ID: 31089103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in regional cerebral blood flow in the thalamus after electroconvulsive therapy for patients with complex regional pain syndrome type 1 (preliminary case series).
    Fukui S; Shigemori S; Nosaka S
    Reg Anesth Pain Med; 2002; 27(5):529-32. PubMed ID: 12373706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-term follow-up of clinical response and regional cerebral blood flow changes in depressed patients treated with ECT.
    Berggren Å; Gustafson L; Höglund P; Johanson A
    J Affect Disord; 2014; 167():235-43. PubMed ID: 24997226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cognitive performance using CNS vital signs after electroconvulsive treatment of schizophrenia.
    Wysokiński A; Dzienniak M; Kłoszewska I
    J ECT; 2014 Mar; 30(1):e5-6. PubMed ID: 24080543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms.
    Martinotti G; Ricci V; Di Nicola M; Caltagirone C; Bria P; Angelucci F
    J ECT; 2011 Mar; 27(1):e44-6. PubMed ID: 21206369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.